Oruka Therapeutics Statistics

Total Valuation

ORKA has a market cap or net worth of $365.04 million. The enterprise value is -$27.70 million.

Market Cap	365.04M
Enterprise Value	-27.70M

Important Dates

The next estimated earnings date is Friday, May 23, 2025, before market open.

Earnings Date	May 23, 2025
Ex-Dividend Date	n/a

Share Statistics

ORKA has 37.44 million shares outstanding.

Current Share Class	37.44M
Shares Outstanding	37.44M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+192.14%
Owned by Insiders (%)	2.52%
Owned by Institutions (%)	64.71%
Float	24.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.96
P/TBV Ratio	0.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 28.89, with a Debt / Equity ratio of 0.00.

Current Ratio	28.89
Quick Ratio	28.80
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-59.48

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-24.87%
Revenue Per Employee	n/a
Profits Per Employee	-$2.53M
Employee Count	28
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.59% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-76.59%
50-Day Moving Average	10.08
200-Day Moving Average	20.54
Relative Strength Index (RSI)	49.17
Average Volume (20 Days)	174,636

Short Selling Information

The latest short interest is 2.66 million, so 7.12% of the outstanding shares have been sold short.

Short Interest	2.66M
Short Previous Month	2.36M
Short % of Shares Out	7.12%
Short % of Float	10.86%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-95.26M
Pretax Income	n/a
Net Income	-70.95M
EBITDA	-95.23M
EBIT	-95.26M
Earnings Per Share (EPS)	-$4.23

Full Income Statement

Balance Sheet

The company has $375.65 million in cash and $968,000 in debt, giving a net cash position of $392.75 million or $10.49 per share.

Cash & Cash Equivalents	375.65M
Total Debt	968,000
Net Cash	392.75M
Net Cash Per Share	$10.49
Equity (Book Value)	382.22M
Book Value Per Share	10.13
Working Capital	363.83M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$63.09 million and capital expenditures -$206,182, giving a free cash flow of -$63.30 million.

Operating Cash Flow	-63.09M
Capital Expenditures	-206,182
Free Cash Flow	-63.30M
FCF Per Share	-$1.69

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ORKA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-19.44%
FCF Yield	-17.34%

Dividend Details

Analyst Forecast

The average price target for ORKA is $39.67, which is 306.87% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$39.67
Price Target Difference	306.87%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on September 3, 2024. It was a reverse split with a ratio of 0.083333333:1.

Last Split Date	Sep 3, 2024
Split Type	Reverse
Split Ratio	0.083333333:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1